To include your compound in the COVID-19 Resource Center, submit it here.

Yervoy Ipilimumab: Phase I/II start

Last month, Roche and its Genentech Inc. unit submitted regulatory applications in the U.S. and Europe for vemurafenib in

Read the full 198 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE